GM25134
LCL from B-Lymphocyte
Description:
CITRULLINEMIA, CLASSIC
ARGININOSUCCINATE SYNTHETASE 1; ASS1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Disorders of the Urea Cycle |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
Hispanic/Latino
|
Ethnicity
|
Hispanic/Latino
|
Country of Origin
|
USA
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
ASS1 |
Chromosomal Location |
9q34 |
Allelic Variant 1 |
GLY156ASP; CITRULLINEMIA |
Identified Mutation |
467G>A (Gly156Asp) |
|
Gene |
ASS1 |
Chromosomal Location |
9q34 |
Allelic Variant 2 |
GLY156ASP; CITRULLINEMIA |
Identified Mutation |
467G>A (Gly156Asp) |
Remarks |
Clinically affected; onset of symptoms at 2 days of age; has had past hyperammonemic events (not caused by an organic acidemia, lysinuric protein intolerance, mitochondrial disorders, congenital lactic academia, fatty acid oxidation defects, or primary liver disease); AS deficiency; pathogenic homozygous mutation in argininosuccinate synthetase gene: c.467G>A (p.GLY156ASP); neurological evaluation and psychological tests performed. |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|